GlassScriptPhysician profile
Kevin Tiwari
NPI 1285029769
$4,574.77
in general payments reported to CMS, 2019-2025
18 companies · $152 in 2025
The $152 reported for 2025 was less than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $817 · 2020: $695 · 2021: $379 · 2022: $1,190 · 2023: $598 · 2024: $745 · 2025: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,495.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,797.58 | 2019-2024 | Proclaim, Ionicrf |
| Boston Scientific Corporation | $887.33 | 2020-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, Na |
| Nevro Corp. | $456.69 | 2022-2024 | Senza |
| Relievant Medsystems, INC. | $365.61 | 2022-2023 | Intracept |
| Medtronic USA, INC. | $283.40 | 2019-2020 | |
| Medtronic, INC. | $274.80 | 2022-2023 | Intellis Adaptivestim |
| Vertos Medical, INC. | $140.86 | 2022-2024 | Mild Device Kit |
| Curonix LLC | $76.27 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Globus Medical, INC. | $54.07 | 2025 | Senza |
| Pacira Pharmaceuticals Incorporated | $48.03 | 2025 | Exparel |
| Pfizer INC. | $34.86 | 2020-2021 | |
| Allergan, INC. | $29.79 | 2020 | |
| Abbvie INC. | $26.93 | 2021 | |
| Averitas Pharma INC. | $23.89 | 2024 | Qutenza |
| Stryker Corporation | $23.70 | 2025 | Mild Device Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $19.92 | 2024 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.55 | 2022 | |
| Saluda Medical Americas, INC. | $14.49 | 2024 | Evoke |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Tiwari listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.